Vitamins A, D, and E play important roles in humans, such as vision function, immune function, bone metabolism, cell growth and differentiation and oxidation resistance. Deficiencies in these vitamins will result in a high prevalence of cardiovascular disease, infection, bone diseases, etc. Preterm infants, especially very low birth weight infants, are at risk of vitamin deficiency. Intravenous perfusion is the most common and widely used method to supply vitamins for the specific population in early life. However, the current dose of vitamin supplied by intravenous perfusion whether can meet the need of growth and development is not sure and the appropriate dose for preterm infants is still uncertain. The purpose of this study is to investigate whether current dose of fat-soluble vitamin supplementation is enough for very low birth weight infants, the safety of high dose of fat-soluble vitamin supplementation, and compare the differences of prevalence of common complications, such as bronchopulmonary dysplasia, patent ductus arteriosus, sepsis, anemia, and neural development between these two groups.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
120
Supplementation of 5 times current dose of fat-soluble vitamins by intravenous perfusion
Supplementation of the current dose of fat-soluble vitamins by intravenous perfusion
First Affiliated Hospital of Xian JiaotongUniversity
Xi'an, Shaanxi, China
RECRUITINGVitamin levels
Change from baseline level of vitamin A, vitamin D, and vitamin E at 4\~6 weeks
Time frame: within 72 hours after birth, 4~6 weeks old
Complications
The prevalence of bronchopulmonary dysplasia, patent ductus arteriosus, sepsis, anemia, intracranial hemorrhage, extrauterine growth retardation, etc.
Time frame: corrected age of 36 weeks
Neural development
White matter disease of the preterm infant, was semiquantitatively assessed from MRI at term-equivalent age based on an established scoring method.
Time frame: corrected age of 40 weeks
Gene polymorphism in vitamin deficiency preterm infants
Association of rs4588 polymorphism in vitamin D receptor gene and rs10766197 polymorphism in the cytochrome P450 family 2 subfamily R member 1 gene with baseline level of vitamin D and change in vitamin D level after 4\~6 weeks' supplementation
Time frame: within 72 hours after birth, 4~6 weeks old
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.